DNA methylation pattern in 16 tumor-related genes in schwannomas

Cancer Genetics and Cytogenetics

Volumn 172, Issue 1, 2007, Pages 84-86

  Bello, M Josefa ^a   Martinez Glez, Victor ^a   Franco Hernandez, Carmen ^a   Pefla Granero, Carolina ^a   de Campos, Jose M ^a   Isla, Alberto ^a   Lassaletta, Luis ^a   Vaquero, Jesus ^a   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DEATH ASSOCIATED PROTEIN KINASE; DNA MISMATCH REPAIR PROTEIN MSH1; ESTROGEN RECEPTOR; GENE PRODUCT; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P14; PROTEIN P16; PROTEIN P73; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VON HIPPEL LINDAU PROTEIN;

CARCINOGENESIS; CRANIAL NERVE; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE DELETION; GENE LOCUS; GENETIC VARIABILITY; HUMAN; LETTER; NEURILEMOMA; NEUROFIBROMATOSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINAL NERVE; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; DNA METHYLATION; FEMALE; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEURILEMMOMA;

EID: 33845427894     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.02.022     Document Type: Letter

References (17)

1. Woodruff J.M., Kourea H.P., Louis D.N., and Scheithauer III W. Schwannoma. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and genetics of tumors of the nervous system. World Health Organization classification of tumours (2000), IARC Press, Lyon 164-166
2. Jacoby L.B., MacCollin M., Louis D.N., Mohney T., Rubio M.P., Pulaski K., Trofatter J.A., Kley N., Seizinger B., Ramesh V., and Gusella F. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3 (1994) 413-419
3. Kino T., Talceshima H., Nakao M., Nishi T., Yamamoto K., Kimura T., Saito Y., Kochi M., Karatsu J.-I., Saya H., and Ushio Y. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cell 6 (2001) 1-54
4. Gonzalez-Gomez P., Mi B., Alonso M.E., Lomas J., Arjona D., de Campos J.M., Vaquero J., Isla A., Lassaletta L., Gutierrez M., Sarasa J.L., and Rey J.A. CpG island methylation in sporadic and neurofibromatosis type 2-associated schwannomas. Clin Cancer Res 9 (2003) 5601-5606
5. Lomas J., Bello M.J., Arjona D., Alonso M.E., Martinez-Glez V., Lopez-Mann I., Amifloso C., de Campos J.M., Isla A., Vaquero J., and Rey J.A. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes Cancer 42 (2005) 314-319
6. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestafia A., and Rey I.A. Clonal chromosome aberrations in neurinomas. Genes Chromosomes Cancer 6 (1993) 206-211
7. Warren C., James L.A., Ranisden R.T., Wallace A., Baser M.E., Varley J.M., and Evans D.G. Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 40 (2003) 802-806
8. Yin D., Xie D., Hofmann W.-K., Miller C.W., Black K.L., and Koeffler H.P. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors. Oncogene 2l (2002) 8372-8378
9. Lasak J.M., Welling D.B., Akhmametyeva E.M., Salloum M., and Chang L.S. Retinobiastoma-cyclin dependent kinase pathway deregulation in vestibular schwannomas. Laryngoscope 112 (2002) 1555-1561
10. Leone P.E., Bello M.J., Mendiola M., Kusak M.E., de Campos J.M., Vaquero J., Sarasa J.L., Pestafla A., and Rey J.A. Allelic status of Ip, 14q, and 22q and NF2 gene mutations in sporadic schwannomas. Int J Mol Med 1 (1998) 887-892
11. Harada K., Toyooka S., Shivapurkar N., Maitra A., Reddy J.L., Mayya H., Miyajima K., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Chaudhary P.M., and Gazdar A.F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62 (2002) 5897-5901
12. Astuti D., Agathanggelou A., Honorio S., Dallol A., Martinsson T., Kogner P., Cummins C., Neumann H.P., Voutilainen R., Dahia P., Eng C., Maher E.R., and Latif F. RASSFJA promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20 (2001) 7573-7577
13. Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mon M., and Croce C.M. Allele loss and promoter hypermethylation of VHL, RAR-/3, RASSFJA, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63 (2003) 3724-3728
14. Park S.-J., Rashid A., Lee J.-H., Kim S.G., Hamilton S.R., and Wu T.-T. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162 (2003) 815-822
15. Li I., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittman M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
16. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H., and Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15 (1997) 356-362
17. Lassaletta L, Bello MJ, del Rio L, Alfonso C, Roda JM, Rey JA, Gavilan J. DNA methylation of multiple genes in vestibu lar schwannoma: relationship with clinical and radiological findings Otology Neurotol 2006;27:1180-5.